Phenylephrine Hydrochloride Market - Top Companies and Manufacturers

Companies Dominating the Phenylephrine Hydrochloride Landscape

There are numerous significant competitors in the fiercely competitive worldwide phenylephrine hydrochloride market. To keep a competitive edge in the market, the major industrial players employ several tactics. Among other tactics, these players are involved in strategic partnerships, mergers, acquisitions, and collaborations. One can gain important knowledge about the competitive environment of this market and strategically position themselves for success in this industry by carefully evaluating each company's phenylephrine hydrochloride market share, considering elements like product offers, production capacity, geographic reach, etc.

Aarti Pharmalabs Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

SNA Healthcare Private Limited
Shenzhen Oriental Pharmaceutical Co., Ltd.
Unichem Laboratories Ltd.
Transo-Pharm Handels GmbH
Hikma Pharmaceuticals PLC
Eton Pharmaceuticals, Inc.
LGM Pharma
AstraZeneca plc
Abbott Laboratories

Browse Key Market Insights with Data Illustration:

Phenylephrine Hydrochloride Market Size, Growth Report 2037

In the News

In December 2023, Hikma Pharmaceuticals PLC introduced Phenylephrine HCl Injection, USP, in dosages of 500 mcg/5 mL and 1,000 mcg/10 mL. Ready-to-use vials of the product have been introduced in the United States. It is recommended to raise blood pressure in people who have clinically significant hypotension, which is mostly caused by vasodilation during anesthesia.
In October 2019, Eton Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that the United States Food and Drug Administration (FDA) approved Biorphen, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically significant hypotension caused primarily by vasodilation during anesthesia.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of phenylephrine hydrochloride was over USD 905.3 million.

The market size for phenylephrine hydrochloride is projected to cross USD 2.4 billion by the end of 2037 expanding at a CAGR of 7.9% during the forecast period i.e., between 2025-2037.

The major players in the market are Aarti Pharmalabs Limited, SNA Healthcare Private Limited, Shenzhen Oriental Pharmaceutical Co., Ltd., Unichem Laboratories Ltd., Transo-Pharm Handels GmbH, Hikma Pharmaceuticals PLC, Eton Pharmaceuticals, Inc., LGM Pharma, AstraZeneca plc, Abbott Laboratories, and others.

The nasal decongestion segment is anticipated to garner a share/size of 95.3% during 2025-2037.

The North America phenylephrine hydrochloride sector is poised to hold a 39.7% share by the end of 2037.

Phenylephrine Hydrochloride Market - Top Companies and Manufacturers

Companies Dominating the Phenylephrine Hydrochloride Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the phenylephrine hydrochloride industry?

What is the outlook for the phenylephrine hydrochloride market?

Who are the major players dominating the phenylephrine hydrochloride landscape?

Which segment will capture the significant market share for phenylephrine hydrochloride by 2037?

Which region will provide more opportunities for the phenylephrine hydrochloride business in 2037?